Part of the Oxford Textbooks in Clinical Neurology series, the Oxford Textbook of Neuro-Oncology is a comprehensive account of the diagnosis, management, and treatment of tumours of the nervous system in children and adults. The second edition covers the most up to date surgical, medical, and radiation therapies of nervous system tumours as well as tumour-related and treatment-related complications.
Chapters are organized according to the widely accepted and referenced World Health Organization (WHO) Classification of Nervous System Tumours, and have been fully updated and expanded based on the most recent 2021 classification.
Written by a global team of authors who are leading, multidisciplinary experts in each of the tumour types covered, this textbook will be a valuable resource for neurologists, neurosurgeons, neuro-oncologists, radiation oncologists, medical oncologists, and trainees in these disciplines.
Part of the Oxford Textbooks in Clinical Neurology series, the Oxford Textbook of Neuro-Oncology covers the pathophysiology, diagnosis, classification, and management of tumours of the nervous system.
Recenzijas
Review from previous edition I highly recommend this text. It is a concise yet complete reference for clinicians wishing to review the latest diagnosis and treatment options. * Neurosurgery *
1: David N. Louis, Pieter Wesseling, and David W. Ellison: Introduction
to WHO Classification of Tumors of the Central Nervous System
2: Michael Weller, Andreas von Deimling, and Daniel Brat: Gliomas,
Glioneuronal, and Neuronal Tumors: Introduction
2.1.1: Martin J. van den Bent, Daniel J. Brat, Frederic Dhermain, and Walter
Stummer: Adult-type diffuse gliomas: Astrocytoma, IDH-Mutant
2.1.2: Wolfgang Wick and Guido Reifenberger: Adult-type diffuse gliomas:
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted
2.1.3: Michael Weller, E. Antonio Chiocca, Sabine Mueller, Jennifer Yu, and
Andreas von Deimling: Adult-type diffuse gliomas: Glioblastoma, IDH-wildtype
2.2: Mariella Filbin, Christine Haberler, Daphne Haas-Kogan, Ian F. Pollack,
David A. Reardon, and Sanda Alexandrescu: Pediatric-type diffuse low-grade
gliomas
2.3: Michelle Monje, Steven BraunsteiMitchell Berger, and Hannes Vogel:
Paediatric-type diffuse high-grade gliomas
2.4: Mariella Filbin, Sanda Alexandrescu, Daphne Haas-Kogan, Ian F. Pollack,
David A. Reardon, Christine Haberler: Circumscribed astrocytic gliomas
2.5: Riccardo Soffietti, Hugues Duffau, Anita Mahajan, Maria Luisa Garrč, and
Jason Huse: Glioneuronal and neuronal tumours
2.6: Mark R. Gilbert, Christina Tsien, Anandani Nellan, Cynthia Campen, Terri
S. Armstrong, Mark Souweidane, and Roger McLendon: Ependymal Tumours
3: Didier Frappaz, Nikolaus Andratschke, Roberta Ruda, Manfred Westphal, and
Christian Thomas: Choroid Plexus Tumours
4: Samuel Cheshier, Franēois Doz, David W. Ellison, Thomas E. Merchant, and
Stefan M. Pfister: Embryonal Tumours
5: Roger E. Taylor, Felice Giangaspero, Catherine Han, Michael Jenkinson, and
Nancy Tarbell: Pineal tumours
6: Joerg Christian Tonn, Warren Mason, Alexander Muacevic, and David Reuss:
Cranial and paraspinal nerve tumours
7: Priscilla K. Brastianos, Roland Goldbrunner, Damien Charles Weber, and
Felix Sahm: Meningioma
8: Sith Sathornsumetee, Rakesh Jalali, Manfred Westphal, and Christian
Mawrin: Mesenchymal, non-meningothelial tumours involving the central nervous
system
9: Patrick Roth, Loreto Yanez, Ying Mao, and Keith Ligon: Melanocytic tumors
10: Tracy Batchelor: Haematolymphoid tumours involving the central nervous
system: Introduction
10.1: Tracy Batchelor, Motoo Nagane, Tejpal Gupta, Lisa Roth, and Maurilio
Ponzoni: Lymphomas
10.2: Oussama Abla and Jennifer Picarsic: Histiocytic Tumors of the Central
Nervous System
11: Manmeet S. Ahluwalia, Matthew D. Hall, Hirokazu Takami, and Torsten
Pietsch: Germ cell tumors
12: Joachim M. Baehring, Helen Shih, Zhong-Ping Chen, and Sandro Santagata:
Tumors of the sellar region
13: Emilie Le Rhun and Dieta Bransdma: Metastases to the CNS: Introduction
13.1: Dieta Brandsma, David Schiff, Susan Short, Marcos Maldaun, and
Elisabeth Rushing: Metastases to the brain and spinal cord parenchyma
13.2: Emilie Le Rhun, Giuseppe Minniti, Adrienne Boire, and Pieter Wesseling:
Metastases to the meninges
13.3: Tali Siegal, Ofir Wolach, and Osnat Bairey: Secondary involvement of
the central nervous system by hematopoietic malignancies
14: Scott R. Plotkin: Genetic tumour syndromes involving the CNS:
Introduction
14.1: Scott R. Plotkin, D. Gareth Evans, Jay Loeffler, Sonia Partap, Shota
Tanaka, and Anat Stemmer-Rachamimov: Neurofibromatosis 1
14.2: Scott R. Plotkin, D. Gareth Evans, Jay Loeffler, Sonia Partap, Shota
Tanaka, and Anat Stemmer-Rachamimov: NF2-related schwannomatosis (formerly
known as neurofibromatosis type 2)
14.3: Scott R. Plotkin, D. Gareth Evans, Jay Loeffler, Sonia Partap, Shota
Tanaka, and Anat Stemmer-Rachamimov: Non-NF2-related schwannomatosis and
rhabdoid tumour predisposition syndrome
14.4: Joachim P. Steinbach, Hiroshi Kanno, Othon Iliopoulos, and Karl H.
Plate: Von Hippel Lindau Disease
14.5: Eleonora Aronica, Pradnya Gadgil, Nisha Giridharan, Howard Weiner,
Peter B. Crino: Tuberous Sclerosis Complex
14.6: Ana S. Guerreiro Stucklin, Uri Tabori, and Cynthia Hawkins: Central and
Peripheral Nervous System Tumor Predisposition Syndromes
Tracy Batchelor is the Chair in the Department of Neurology at Brigham and Women's Hospital, Co-Leader of the Neuro-Oncology Program at the Dana-Farber/Harvard Cancer Center, and the Martin A. Samuels Professor of Neurology at Harvard Medical School, Boston, USA. He has spent his career focused on developing novel therapeutics for malignant brain tumours.
Michael Weller is the Chair in the Department of Neurology at University Hospital and University of Zurich, Switzerland. He served as President of the European Association of Neuro-Oncology and chaired the EORTC Brain Tumour Group. His research focuses on innovative therapeutic approaches to brain tumours in vitro, in experimental models in vivo, and in clinical trials.
